Led by Dr. Jennifer Gordon, the Chair of the Clinical Advisory Board for IAPMD, this engaging session will highlight the most significant advancements in premenstrual disorder research from the past year and what they mean for patients, providers, and the future of care.
Summary
This webinar reviews three 2025 studies that advance understanding of hormone sensitivity, menstrual-cycle modelling, and medication safety. Participants will gain insights into the following learning outcomes:
- A major replication study confirmed that PMDD is a hormone-sensitivity condition, with symptoms returning only when hormones are added back.
- New menstrual-cycle tracking methods improve how researchers study hormone changes, making findings more accurate.
- Long-term medication patterns show how easily treatments can become unsafe, underscoring the need for regular medication reviews.
